Catalyst Event
Gilead Sciences Inc (GILD) · Other
From Akros U.S. Tech 100 Index (AUT100)
4/14/2026, 12:00:00 AM
PEPFAR and The Global Fund are expected to announce an additional investment in Gilead's lenacapavir on April 14, 2026, to expand access in resource-limited countries. Low importance is estimated as revenue impact is likely under 1% expected.
Korean Translation
2026년 4월 14일 저소득 국가의 접근성 확대를 위한 PEPFAR 및 글로벌 펀드의 레나카파비르 추가 투자 발표가 있음. 매출 영향은 1% 미만일 것으로 보여 중요도를 'Low'로 예상함 예상됨.
Related Recent Events
Cloudflare Inc (NET) · Other
Cloudflare is scheduled to host an Investor Day on June 9, 2026; a >=5% price impact is estimated as the company provides strategic updates scheduled.
6/9/2026, 12:00:00 AM
Medtronic PLC (MDT) · Earnings Release
Medtronic will report its financial results for the fourth quarter and full fiscal year 2026 on June 3, 2026 (High importance estimated due to potential volatility from annual results), scheduled.
6/3/2026, 12:00:00 AM
Hewlett Packard Enterprise Co (HPE) · Earnings Release
Q2 2026 earnings release is scheduled.
6/2/2026, 12:00:00 AM
Marvell Technology Inc (MRVL) · Earnings Release
First quarter fiscal year 2027 earnings results are scheduled to be released on May 29, 2026. Market impact is estimated at >1% as earnings releases typically drive volatility scheduled.
5/29/2026, 12:00:00 AM
Analog Devices Inc (ADI) · Earnings Release
Analog Devices is expected to release its fiscal second quarter 2026 financial results around late May. The date is estimated based on previous reporting schedules and is scheduled.
5/28/2026, 12:00:00 AM
Axon Enterprise Inc (AXON) · Other
Axon's Annual Meeting of Shareholders on 2026-05-28 where director Matthew McBrady will not seek re-election, which is estimated to have low importance as board changes are common, is scheduled.
5/28/2026, 12:00:00 AM